Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years
Author:
Affiliation:
1. Rabin Medical Center, Tel Aviv University Sackler School of Medicine, Tel Aviv, Israel
2. Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jama/articlepdf/2786096/jama_eliakimraz_2021_ld_210075_1637771571.44708.pdf
Reference6 articles.
1. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates.;Walsh;N Engl J Med,2020
2. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months.;Levin;N Engl J Med,2021
3. Antibody response after a third dose of the MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients with minimal serologic response to 2 doses.;Benotmane;JAMA,2021
4. Protection of BNT162b2 vaccine booster against Covid-19 in Israel.;Bar-On;N Engl J Med,2021
5. Association of SARS-CoV-2 seropositive antibody test with risk of future infection.;Harvey;JAMA Intern Med,2021
Cited by 104 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Demographic and Clinical Factors Associated With SARS-CoV-2 Spike 1 Antibody Response Among Vaccinated US Adults: the C4R Study;Nature Communications;2024-02-19
2. Dynamics of Anti-SARS-CoV-2 IgA and IgG Responses and Their Protective Effect against Fatal Disease after Booster COVID-19 Vaccination;Vaccines;2023-12-21
3. Febrile Reactions Associated with High IgG Antibody Titers after the Second and Third BNT162b2 Vaccinations in Japan;Japanese Journal of Infectious Diseases;2023-09-30
4. Factors associated with antibody titer levels among an occupational cohort of fully vaccinated individuals and subsequent risk of COVID‐19 infection: A cohort study;Journal of Medical Virology;2023-08
5. Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases;Vaccines;2023-07-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3